Lentivirus production is influenced by SV40 large T-antigen and chromosomal integration of the vector in HEK293 cells.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Alves, Paula Marques
MetadataShow full item record
AbstractCurrently, lentiviral vectors for research and gene therapy are produced from 293-T cells that are transiently transfected with plasmids encoding the vector and helper functions. However, transiently transfected vectors as well as the presence of SV40 virus large T-antigen (T-Ag) cause serious technical and safety considerations. We aimed to exploit single copy integration sites in the HEK293 genome supporting lentiviral vector production. We found that lentiviral vectors result in minimal infectious particle production from single copy integrants in HEK293. Moreover, once this cell line harbors single copy integrations of lentiviral vectors, its ability to transiently produce lentiviral vectors becomes strongly impaired. T-Ag has a dramatic effect on virus production. Low levels of constitutive T-Ag expression can overcome the production restriction imposed by integrated lentiviral vectors copies. Interestingly, T-Ag does not exert its role at the level of transcriptional activity of the vector; rather, it seems to impose an indirect effect on the cell thereby enabling lentiviral vector production. Altogether, our study highlights the restrictions for integrated lentiviral vectors that are relevant for the establishment of stable and safe producer cell lines.
CitationLentivirus production is influenced by SV40 large T-antigen and chromosomal integration of the vector in HEK293 cells. 2011, 22 (10):1269-79 Hum. Gene Ther.
AffiliationHelmholtz Centre for Infection Research, Braunschweig, Germany .
JournalHuman gene therapy
The following license files are associated with this item:
- Generation of a packaging cell line for prolonged large-scale production of high-titer HIV-1-based lentiviral vector.
- Authors: Ni Y, Sun S, Oparaocha I, Humeau L, Davis B, Cohen R, Binder G, Chang YN, Slepushkin V, Dropulic B
- Issue date: 2005 Jun
- Transient proteasome inhibition as a strategy to enhance lentiviral transduction of hematopoietic CD34(+) cells and T lymphocytes: implications for the use of low viral doses and large-size vectors.
- Authors: Leuci V, Mesiano G, Gammaitoni L, Cammarata C, Capellero S, Todorovic M, Jordaney N, Circosta P, Elia A, Lesnikova M, Georges GE, Piacibello W, Fagioli F, Cignetti A, Aglietta M, Sangiolo D
- Issue date: 2011 Dec 10
- Lentiviral vector integration sites in human NOD/SCID repopulating cells.
- Authors: Laufs S, Guenechea G, Gonzalez-Murillo A, Zsuzsanna Nagy K, Luz Lozano M, del Val C, Jonnakuty S, Hotz-Wagenblatt A, Jens Zeller W, Bueren JA, Fruehauf S
- Issue date: 2006 Oct
- Generation of lentiviral vectors for use in skeletal muscle research.
- Authors: Pichavant C, Tremblay JP
- Issue date: 2012
- Production of lentiviral vectors for transducing cells from the central nervous system.
- Authors: Li M, Husic N, Lin Y, Snider BJ
- Issue date: 2012 May 24